Clinical Trial Update: Rosuvastatin Adherence App Study in China [NA]

View source ↗

Summary

AstraZeneca-sponsored clinical trial in China evaluating a rosuvastatin adherence app for dyslipidemia/hyperlipidemia has completed, with results posted January…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia, Hyperlipidemia | NA | Status: COMPLETED | Results posted: 2019-01-31